Orchard Therapeutics GAAP EPS of -$0.40 misses by $0.14, revenue of $4.37M beats by $1.19M

Aug. 04, 2022 8:57 AM ETOrchard Therapeutics plc (ORTX)By: Deepa Sarvaiya, SA News Editor
  • Orchard Therapeutics press release (NASDAQ:ORTX): Q2 GAAP EPS of -$0.40 misses by $0.14.
  • Revenue of $4.37M beats by $1.19M.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.